Idea Therapeutics is a Spanish biotech start-up focused on advanced therapy medicinal products (ATMPs), aiming to address diseases with limited therapeutic options. Our current research projects focus on regenerative medicine and immunology, with a long-term vision of expanding into other high-impact therapeutic areas such as oncology.

At Idea Tx, we believe in the transformative power of science. Our mission is to investigate and develop disruptive ideas into new research lines in the field of ATMPs. We follow an open innovation model through strategic partnerships with leading public and private hospitals and research centers, integrating the entire value chain and driving the development of advanced therapies from early research to manufacturing, under Good Manufacturing Practice (GMP) standards.

Idea Therapeutics was founded by a team of senior healthcare executives from FARMALIDER, a Spanish pharmaceutical company with a strong track record in the development of prescription drugs, OTC products, and value-added formulations for the international B2B market. The project is led by Marisa Berenguer, CEO of FARMALIDER, and José Ángel Sánchez, PhD, Innovation Director at Idea Tx.

Our first milestone is AGAcell® (https://agacell.com), a preclinical research program investigating a patented allogeneic mesenchymal stem cell–based formulation for androgenetic alopecia.

Idea Tx is currently evaluating AGAcell® as a potential cell-based investigational strategy aimed at restoring the follicular microenvironment and promoting hair regeneration through a minimally invasive, non-surgical procedure. The program is led by Principal Investigator Dr. Eduardo López Bran, PhD, an internationally recognized dermatologist in the field of trichology and Head of the Dermatology Department at Hospital Clínico San Carlos in Madrid and funded by the Spanish Centre for the Development of Technology and Innovation (CDTI)

Idea Therapeutics

Org chart

Teams

Offices

Idea Therapeutics

Org chart

Teams

Offices

Related companies